Vanguard Group Inc Cytokinetics Inc Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 11,915,821 shares of CYTK stock, worth $451 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,915,821

Previous 11,761,605 1.31%

Holding current value

$451 Million

Previous $621 Million 9.74%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$46.36 - $58.62 $7.15 Million - $9.04 Million	154,216 Added 1.31%	11,915,821 $561 Million
Q3 2024 Nov 13, 2024	BUY	$51.22 - $60.16 $16.6 Million - $19.5 Million	323,909 Added 2.83%	11,761,605 $621 Million
Q2 2024 Aug 13, 2024	BUY	$47.86 - $75.05 $68.9 Million - $108 Million	1,440,620 Added 14.41%	11,437,696 $620 Million
Q1 2024 May 10, 2024	SELL	$63.75 - $108.06 $65 Million - $110 Million	-1,019,813 Reduced 9.26%	9,997,076 $701 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $7.35 Million - $22.8 Million	273,565 Added 2.55%	11,016,889 $920 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $13.9 Million - $17.3 Million	472,595 Added 4.6%	10,743,324 $316 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $2.85 Million - $3.56 Million	87,397 Added 0.86%	10,270,729 $335 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $3.68 Million - $5.04 Million	110,238 Added 1.09%	10,183,332 $358 Million
Q4 2022 Feb 10, 2023	BUY	$35.77 - $51.11 $2.92 Million - $4.18 Million	81,760 Added 0.82%	10,073,094 $462 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $39.7 Million - $56.2 Million	1,031,114 Added 11.51%	9,991,334 $484 Million
Q2 2022 Aug 12, 2022	BUY	$33.93 - $48.92 $7.43 Million - $10.7 Million	219,096 Added 2.51%	8,960,220 $352 Million
Q1 2022 May 13, 2022	BUY	$29.74 - $46.0 $52.1 Million - $80.6 Million	1,751,405 Added 25.06%	8,741,124 $322 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $57.5 Million - $77.7 Million	1,675,188 Added 31.52%	6,989,719 $319 Million
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $10.9 Million - $21 Million	588,842 Added 12.46%	5,314,531 $190 Million
Q2 2021 Aug 13, 2021	BUY	$19.79 - $26.99 $93.5 Million - $128 Million	4,725,689 New	4,725,689 $93.5 Million

Others Institutions Holding CYTK

# of Institutions

400

Shares Held

115M

Call Options Held

3.46M

Put Options Held

1.86M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.56B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Cytokinetics Inc Transaction History